Brief: China Resources Pharmaceutical Group Posts H1 Net Income Of RMB 5,540.6 Million
Aug 29 (Reuters) - China Resources Pharmaceutical Group H1 gross margin 16.3%. * H1 gross profit RMB 20,933.5 million * H1 revenue RMB 128,597 million * H1 net income RMB 5,540.6 million
Recent news on China Resources Pharmaceutical
See all newsBrief: China Resources Pharmaceutical Group Declares Interim Dividend Of RMB0.087 Per Share
Brief: China Resources Pharmaceutical Says Tasly Pharmaceutical Posts HY Net Profit Attributable Of RMB 892.7 MLN
Brief: China Resources Pharmaceutical Group Says HY Revenue RMB 1.93 Billion For CR Jiangzhong
Brief: China Resources Pharmaceutical Group Posts HY Revenue RMB 1.64 Billion, Down 50.97% For KPC Pharmaceuticals
Brief: China Resources Pharmaceutical Says CR Boya Bio-Pharmaceutical Posts Quarterly Unaudited Revenue RMB 321.1 Million, Net Profit RMB 30.0 Million